NCT05568524Completed
Resistance Training With Blood Flow Restriction in Hemophilia
The Acute and Chronic Impact of Blood Flow Restriction Resistance Training on Physical and Neuromuscular Function, Pain, and Quality of Life in Patients With Moderate/Severe Hemophilia
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
The main objectives of this study are to evaluate safety and chronic effects of a low-load resistance exercise intervention (elbow flexions and extensions, and knee extensions) with blood flow restriction in people with hemophilia on quality of life, pain, and on physical and neuromuscular function.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 29 Sept 2022
- Start date
- 15 Jan 2024
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- University of Valencia
- Diseases
- Haemophilia
- NCT number
- NCT05568524
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 15 Jan 2024 to the primary completion date, 30 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- surgical procedures performed 6 weeks prior to or during the exercise program; - participation in any other form of exercise, not previously done, during the study;
- changes in medication during the study;
- need for major surgery;
Other illness
- a major bleeding episode that posed a risk or prevented exercise;
Other
- the inability to attend exercise sessions at least twice a week for 8 consecutive weeks;
- non adherence to instruction on proper exercise technique;
- another hemostatic defect;
- withdrawal of informed consent.
Who the study is looking for
- diagnosis of hemophilia A or B and undergoing prophylaxis;
- willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations;
- approval by their hematologist to participate in the exercise program;
- age between 18 and 60 years;
- informed consent signed.
Age in the registry: 18 years to 60 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Facultat de Fisioteràpia Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.